Puay Hoon Tan

Title: Puay Hoon Tan: Innovator in Cancer Prognosis and Treatment

Introduction

Puay Hoon Tan is a distinguished inventor based in Singapore, known for his significant contributions to the field of medical diagnostics and treatment. He holds two patents that focus on innovative methods for determining the type of fibroepithelial tumors and managing renal cancer prognosis. His work is pivotal in enhancing the accuracy of cancer diagnosis and treatment strategies.

Latest Patents

Tan's latest patents include a multigene assay that provides an in vitro method for determining the type of fibroepithelial tumor of the breast in a biological sample. This method involves obtaining an expression profile of various genes and correlating their differential activity to classify the tumor type. A p-score is calculated to indicate whether the tumor is a fibroadenoma or a phyllodes tumor. Additionally, he has developed a method for making a prognosis for patients with renal cancer by analyzing the expression levels of specific markers in tumor tissue samples. This innovative approach aids in predicting patient survival based on the expression parameters of selected genes.

Career Highlights

Puay Hoon Tan is currently associated with Lucence Life Sciences Pte Ltd., where he continues to advance his research in cancer diagnostics. His work is characterized by a commitment to improving patient outcomes through innovative medical technologies.

Collaborations

Tan collaborates with notable colleagues, including Min-Han Tan and Wai Jin Tan, contributing to a dynamic research environment that fosters innovation in cancer treatment.

Conclusion

Puay Hoon Tan's contributions to cancer diagnostics and treatment exemplify the impact of innovative thinking in medicine. His patents reflect a dedication to improving patient care through advanced scientific methods.